Question to the Department of Health and Social Care:
To ask Her Majesty’s Government whether the Cancer Drugs Fund is to continue to fund any drugs where the appropriate company refused to make appropriate adjustment to their prices and where it failed to meet the value for money test.
A drug may be funded in exceptional circumstances via the individual funding route. In addition, a drug may be retained in the Cancer Drugs Fund in an indication where it provides greater clinical benefit than the indication for which it has been removed.